These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 13426747)

  • 21. [Therapeutic trials with TWSb (dimercaptosuccinate of antimony) in vesical bilharziasis. I. Results obtained in a school infirmary (Hospital do Ultramar) in Lisbon. II. Results obtained in the Hospital de S. Paulo de Luanda. III. Results obtained in Guinea in the infirmary of the Endemia Mission].
    OLIVEIRA CF; ROCHA RM; LEITAO MS; SA AP; BARBOSA F; ATAIDE P; CRUZ FS; da CUNHA C; GARCIA LN
    An Inst Med Trop (Lisb); 1960 Sep; 17():669-96. PubMed ID: 14481781
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of schistosomiasis caused by S. haematobium.
    VAN BEUKERING JA
    Doc Med Geogr Trop; 1957 Sep; 9(3):259-60. PubMed ID: 13473697
    [No Abstract]   [Full Text] [Related]  

  • 23. Genitourinary schistosomiasis.
    Al-Ghorab MM; Smith DR
    Trans Am Assoc Genitourin Surg; 1979; 71():70-5. PubMed ID: 545818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium antimony dimercaptosuccinate (Sb-58) in treatment of schistosomiasis japonica.
    HSU JK; WU YS; LU CP; CH'EN MK; LU CS
    Chin Med J; 1960 Jun; 80():530-7. PubMed ID: 13716378
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sodium antimony-meso 2,3 dimercapto-succinate in intestinal schistosomiasis].
    de Oliveira C; de Mendonça LE
    Hospital (Rio J); 1968 Jan; 73(1):253-7. PubMed ID: 5308501
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 28. Astiban therapy of urinary schistosomiasis: a quantitative evaluation.
    Farid Z; Bassily S; Schulert A; McConnell E
    Ann Trop Med Parasitol; 1966 Jun; 60(2):165-8. PubMed ID: 5962469
    [No Abstract]   [Full Text] [Related]  

  • 29. ON THE SHORT-TERM ANTIBILHARZIAL THERAPY WITH SODIUM ANTIMONY DIMERCAPTOSUCCINATE.
    ABDALLA A; SAIF M; ABDEL-FATTAH F
    J Egypt Med Assoc; 1963; 46():188-96. PubMed ID: 14058973
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimony dimercaptosuccinate (TWSb) in the treatment of urinary bilharziasis in Somalia.
    BARUFFA G; FRIEDHEIM EA
    Cent Afr J Med; 1960 Nov; 6():485-7. PubMed ID: 13687532
    [No Abstract]   [Full Text] [Related]  

  • 31. HUMAN DISPOSITION OF ANTIMONY ADMINISTERED AS ANTIMONY SODIUM DIMERCAPTO-SUCCINATE. WITH AN ANALYSIS OF ANTIMONY CONCENTRATION IN EXCRETED SCHISTOSOMA HAEMATOBIUM OVA.
    SCHULERT AR; BROWNE HG; SALEM HH
    Trans R Soc Trop Med Hyg; 1964 Jan; 58():48-52. PubMed ID: 14117554
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis.
    el-Zayadi AM; Shoeb SM; Sabour MS; Basmy K
    Tropenmed Parasitol; 1974 Jun; 25(2):147-52. PubMed ID: 4418544
    [No Abstract]   [Full Text] [Related]  

  • 33. Further studies on antimony dimercapto succinate (TWSb) in urinary bilharziasis.
    ALVES W
    Cent Afr J Med; 1959 Jun; 5(6):291. PubMed ID: 13671500
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative antimony disposition following administration of tartar emetic and sodium antimony dimercaptosuccinate (Astiban) to hamsters infected with Schistosoma mansoni.
    Schulert AR; Girgis NI; Girgis GR; Farid Z; McConnell E
    East Afr Med J; 1967 Jan; 44(1):1-8. PubMed ID: 6038793
    [No Abstract]   [Full Text] [Related]  

  • 35. Symptomatic, radiological, and functional improvement following treatment of urinary schistosomiasis in Egypt.
    Farid Z; Bassily S; McConnell E; Schulert A; Sabour M; Abdel Wahab MF
    Lancet; 1967 Nov; 2(7526):1110-3. PubMed ID: 4168554
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of schistosomiasis; discussion.
    ANDERSON HH
    Am J Trop Med Hyg; 1955 May; 4(3):460. PubMed ID: 14376769
    [No Abstract]   [Full Text] [Related]  

  • 37. Intestinal schistosomiasis a comparative therapeutic trial.
    Abo-el-Enein Mel-S ; Sheir ZM; Amer ZM; el-Basousy E
    J Egypt Med Assoc; 1972; 55(1):69-75. PubMed ID: 4340485
    [No Abstract]   [Full Text] [Related]  

  • 38. [A comparison of nitroth- iamidazole tolerance and dimercapto-succinate of antimony tolerance in antibilharzic therapy].
    Spitaels JM; Bounameaux Y; Parkinson-Boné L
    Ann Soc Belges Med Trop Parasitol Mycol; 1967; 47(5):349-60. PubMed ID: 5595224
    [No Abstract]   [Full Text] [Related]  

  • 39. The carbohydrate metabolism of Schistosoma mansoni and some effects of ambilhar and astiban.
    Magzoub M; Fletcher KA; Maegraith BG
    Trans R Soc Trop Med Hyg; 1969; 63(1):16. PubMed ID: 5789093
    [No Abstract]   [Full Text] [Related]  

  • 40. Some quantitative aspects of bilharzia with particular referecne to suppressive therapy and mollusciciding in control of S. haematobium in Sukumaland, Tanganyika.
    JORDAN P
    East Afr Med J; 1963 May; 40():250-60. PubMed ID: 14042001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.